News for Healthier Living

"Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns

Value in Health, the official journal of ISPOR--The Professional Society for Health Economics and Outcomes Research, announced today the publication of a new analysis suggesting that the Trump Administration's "Most-Favored Nation" approach to lowering US drug prices by referencing international prices may not achieve its intended goals, based on decades of experience with similar policies in Europe.

September 3, 2025


September 3 2025

September 2 2025

September 1 2025

August 31 2025

August 30 2025

August 29 2025

August 28 2025

August 27 2025

August 26 2025

August 25 2025

August 24 2025

August 23 2025

August 22 2025

August 21 2025

August 20 2025